Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

CASSAVA SCIENCES INC (PTIE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates"
05/01/2023 8-K Quarterly results
Docs: "Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates"
02/28/2023 8-K Quarterly results
Docs: "Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates"
11/07/2022 8-K Quarterly results
Docs: "Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates – $174.7 Million Cash and Cash Equivalents at September 30, 2022 – – Over 650 Patients Now Enrolled in Phase 3 Program - – New Clinical Data for Simufilam in Alzheimer’s Disease Expected –"
08/03/2022 8-K Quarterly results
Docs: "Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study"
05/05/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
Docs: "Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates"
11/10/2021 8-K Quarterly results
Docs: "Cassava Sciences Reports Third Quarter 2021 Financial Results"
08/03/2021 8-K Quarterly results
04/21/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "Cassava Sciences Reports Third Quarter 2020 Financial Results"
08/12/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
03/26/2020 8-K Quarterly results
10/29/2019 8-K Quarterly results
08/12/2019 8-K Quarterly results
Docs: "Cassava Sciences Announces Second Quarter 2019 Financial Results"
04/29/2019 8-K Quarterly results
Docs: "Cassava Sciences Reports First Quarter 2019 Financial Results 2019 Focus is on Fiscal Discipline and Advancing Development Pipeline"
10/29/2018 8-K Quarterly results
Docs: "Pain Therapeutics Reports Third Quarter 2018 Financial Results"
07/26/2018 8-K Quarterly results
Docs: "Pain Therapeutics Reports Second Quarter 2018 Financial Results"
05/09/2018 8-K Quarterly results
Docs: "Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER – June 26 th Advisory Committee Meeting for REMOXY ER – – August 7th PDUFA Target Date for REMOXY ER –"
11/01/2017 8-K Quarterly results
08/09/2017 8-K Quarterly results
Docs: "Pain Therapeutics Reports Q2 2017 Financial Results And Mid-year Corporate Update"
04/25/2017 8-K Form 8-K - Current report
10/20/2016 8-K Quarterly results
Docs: "Pain Therapeutics Reports Q3 2016 Financial Results"
07/19/2016 8-K Form 8-K - Current report
05/05/2016 8-K Quarterly results
Docs: "Pain Therapeutics Reports Q1 2016 Financial Results"
11/03/2011 8-K Form 8-K - Current report
04/27/2011 8-K Form 8-K - Current report
10/28/2010 8-K Form 8-K - Current report
07/28/2010 8-K Form 8-K - Current report
04/28/2010 8-K Form 8-K - Current report
10/29/2009 8-K Form 8-K - Current report
08/04/2009 8-K Quarterly results
Docs: "Pain Therapeutics Reviews Mid-Year Progress, Reports Second Quarter 2009 Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy